Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

Background: Tocilizumab has been proposed as a treatment for the new disease COVID-19, however, there is not enough scientific evidence to support this treatment. The objective of this study is to analyze whether the use of tocilizumab is associated with respiratory improvement and a shorter time to...

Full description

Bibliographic Details
Main Authors: Alejandro Rodríguez-Molinero, Carlos Pérez-López, César Gálvez-Barrón, Antonio Miñarro, Oscar Macho, Gabriela F. López, Maria Teresa Robles, Maria Dolores Dapena, Sergi Martínez, Ezequiel Rodríguez, Isabel Collado Pérez, Anna Alberti Casas, Jose L. Avalos Garcia, Manel Borrego Ruiz, Gemma Añaños Carrasco, Pedro L. Campo Pisa, Ana M. Capielo Fornerino, Antonio Chamero Pastilla, Andreu Fenollosa Artés, Clara Gris Ambros, Lourdes Hernandez Martinez, Antonio Hidalgo García, Mireia Martín Puig, Núria Milà Ràfols, José C. Molina Hinojosa, Ernesto E. Monaco, Laura Peramiquel Fonollosa, Italo G. Pisani Zambrano, Juan P. Rives, Enric Sabria Bach, Yris M. Sanchez Rodriguez, Maria del Mar Segura Martin, Gemma Tremosa Llurba, Ester Ventosa Gili, Florencia I. Venturini Cabanellas, Natàlia Vidal Meler
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:One Health
Subjects:
Tocilizumab
Efficacy
Coronavirus
Sars-cov-2
Observational study
Cohort
Online Access:http://www.sciencedirect.com/science/article/pii/S2352771421000045

Similar Items

Similar Items